JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=588116, encodeId=58ae588116dd, content=要不要审稿费和版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e7d5210714, createdName=1475c685m18暂无昵称, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573505, encodeId=7b7f5e350546, content=肿瘤的基础研究可以投该期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572307, encodeId=f0c95e2307af, content=@krygios 这个杂志还是偏临床和外科的。干细胞类，找别的期刊更合适一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Jun 16 08:53:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572297, encodeId=efaa5e22975e, content=看到12年发表过一篇和我类似的干细胞修复的基础文章，虽然和杂志现在发表的文章格格不入，前几天还是投了一篇，两天秒拒，拒稿模板说只有10%的命中率，看来这个杂志不喜欢我这种题材的，记录一下，以后不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Jun 15 00:00:00 CST 2019, time=2019-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559326, encodeId=44fb559326d1, content=天呐回顾性研究就死路一条了吗先发个分发表投稿成功后状态一周后拒稿理由是回顾性研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ea22192665, createdName=小肥皂, createdTime=Wed Jul 18 00:00:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544025, encodeId=f5df544025fc, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538357, encodeId=98ec53835ee5, content=投稿成功后状态with editor，一周后拒稿，理由是：回顾性研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTkmXU3e5UIm0T3bND74pKNJ481WHRDc02oib8mVWhEyibkuorcDfhiaMwS2OXib3cuiaF1FZQxv0qung/132, createdBy=3e231985516, createdName=先发个20分, createdTime=Fri Jun 23 00:00:00 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518152, encodeId=aa695181521c, content=审稿速度:1.0 经验分享：初始状态accept with revision，修回后3小时接受。神奇的杂志。今年实验室连中两篇，很好投的样子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15c21626952, createdName=SagoWei, createdTime=Fri Jan 08 16:01:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481389, encodeId=e9bc48138950, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2020-04-03 1475c685m18暂无昵称

要不要审稿费和版面费

142 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=588116, encodeId=58ae588116dd, content=要不要审稿费和版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e7d5210714, createdName=1475c685m18暂无昵称, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573505, encodeId=7b7f5e350546, content=肿瘤的基础研究可以投该期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572307, encodeId=f0c95e2307af, content=@krygios 这个杂志还是偏临床和外科的。干细胞类，找别的期刊更合适一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Jun 16 08:53:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572297, encodeId=efaa5e22975e, content=看到12年发表过一篇和我类似的干细胞修复的基础文章，虽然和杂志现在发表的文章格格不入，前几天还是投了一篇，两天秒拒，拒稿模板说只有10%的命中率，看来这个杂志不喜欢我这种题材的，记录一下，以后不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Jun 15 00:00:00 CST 2019, time=2019-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559326, encodeId=44fb559326d1, content=天呐回顾性研究就死路一条了吗先发个分发表投稿成功后状态一周后拒稿理由是回顾性研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ea22192665, createdName=小肥皂, createdTime=Wed Jul 18 00:00:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544025, encodeId=f5df544025fc, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538357, encodeId=98ec53835ee5, content=投稿成功后状态with editor，一周后拒稿，理由是：回顾性研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTkmXU3e5UIm0T3bND74pKNJ481WHRDc02oib8mVWhEyibkuorcDfhiaMwS2OXib3cuiaF1FZQxv0qung/132, createdBy=3e231985516, createdName=先发个20分, createdTime=Fri Jun 23 00:00:00 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518152, encodeId=aa695181521c, content=审稿速度:1.0 经验分享：初始状态accept with revision，修回后3小时接受。神奇的杂志。今年实验室连中两篇，很好投的样子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15c21626952, createdName=SagoWei, createdTime=Fri Jan 08 16:01:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481389, encodeId=e9bc48138950, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2019-07-09 千军独木

肿瘤的基础研究可以投该期刊吗

193 0

[GetPortalCommentsPageByObjectIdResponse(id=588116, encodeId=58ae588116dd, content=要不要审稿费和版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e7d5210714, createdName=1475c685m18暂无昵称, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573505, encodeId=7b7f5e350546, content=肿瘤的基础研究可以投该期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572307, encodeId=f0c95e2307af, content=@krygios 这个杂志还是偏临床和外科的。干细胞类，找别的期刊更合适一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Jun 16 08:53:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572297, encodeId=efaa5e22975e, content=看到12年发表过一篇和我类似的干细胞修复的基础文章，虽然和杂志现在发表的文章格格不入，前几天还是投了一篇，两天秒拒，拒稿模板说只有10%的命中率，看来这个杂志不喜欢我这种题材的，记录一下，以后不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Jun 15 00:00:00 CST 2019, time=2019-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559326, encodeId=44fb559326d1, content=天呐回顾性研究就死路一条了吗先发个分发表投稿成功后状态一周后拒稿理由是回顾性研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ea22192665, createdName=小肥皂, createdTime=Wed Jul 18 00:00:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544025, encodeId=f5df544025fc, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538357, encodeId=98ec53835ee5, content=投稿成功后状态with editor，一周后拒稿，理由是：回顾性研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTkmXU3e5UIm0T3bND74pKNJ481WHRDc02oib8mVWhEyibkuorcDfhiaMwS2OXib3cuiaF1FZQxv0qung/132, createdBy=3e231985516, createdName=先发个20分, createdTime=Fri Jun 23 00:00:00 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518152, encodeId=aa695181521c, content=审稿速度:1.0 经验分享：初始状态accept with revision，修回后3小时接受。神奇的杂志。今年实验室连中两篇，很好投的样子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15c21626952, createdName=SagoWei, createdTime=Fri Jan 08 16:01:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481389, encodeId=e9bc48138950, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2019-06-16 lovetcm

@krygios 这个杂志还是偏临床和外科的。干细胞类，找别的期刊更合适一些

167 0

[GetPortalCommentsPageByObjectIdResponse(id=588116, encodeId=58ae588116dd, content=要不要审稿费和版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e7d5210714, createdName=1475c685m18暂无昵称, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573505, encodeId=7b7f5e350546, content=肿瘤的基础研究可以投该期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572307, encodeId=f0c95e2307af, content=@krygios 这个杂志还是偏临床和外科的。干细胞类，找别的期刊更合适一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Jun 16 08:53:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572297, encodeId=efaa5e22975e, content=看到12年发表过一篇和我类似的干细胞修复的基础文章，虽然和杂志现在发表的文章格格不入，前几天还是投了一篇，两天秒拒，拒稿模板说只有10%的命中率，看来这个杂志不喜欢我这种题材的，记录一下，以后不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Jun 15 00:00:00 CST 2019, time=2019-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559326, encodeId=44fb559326d1, content=天呐回顾性研究就死路一条了吗先发个分发表投稿成功后状态一周后拒稿理由是回顾性研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ea22192665, createdName=小肥皂, createdTime=Wed Jul 18 00:00:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544025, encodeId=f5df544025fc, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538357, encodeId=98ec53835ee5, content=投稿成功后状态with editor，一周后拒稿，理由是：回顾性研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTkmXU3e5UIm0T3bND74pKNJ481WHRDc02oib8mVWhEyibkuorcDfhiaMwS2OXib3cuiaF1FZQxv0qung/132, createdBy=3e231985516, createdName=先发个20分, createdTime=Fri Jun 23 00:00:00 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518152, encodeId=aa695181521c, content=审稿速度:1.0 经验分享：初始状态accept with revision，修回后3小时接受。神奇的杂志。今年实验室连中两篇，很好投的样子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15c21626952, createdName=SagoWei, createdTime=Fri Jan 08 16:01:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481389, encodeId=e9bc48138950, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2019-06-15 krygios

看到12年发表过一篇和我类似的干细胞修复的基础文章，虽然和杂志现在发表的文章格格不入，前几天还是投了一篇，两天秒拒，拒稿模板说只有10%的命中率，看来这个杂志不喜欢我这种题材的，记录一下，以后不会再投

196 0

[GetPortalCommentsPageByObjectIdResponse(id=588116, encodeId=58ae588116dd, content=要不要审稿费和版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e7d5210714, createdName=1475c685m18暂无昵称, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573505, encodeId=7b7f5e350546, content=肿瘤的基础研究可以投该期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572307, encodeId=f0c95e2307af, content=@krygios 这个杂志还是偏临床和外科的。干细胞类，找别的期刊更合适一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Jun 16 08:53:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572297, encodeId=efaa5e22975e, content=看到12年发表过一篇和我类似的干细胞修复的基础文章，虽然和杂志现在发表的文章格格不入，前几天还是投了一篇，两天秒拒，拒稿模板说只有10%的命中率，看来这个杂志不喜欢我这种题材的，记录一下，以后不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Jun 15 00:00:00 CST 2019, time=2019-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559326, encodeId=44fb559326d1, content=天呐回顾性研究就死路一条了吗先发个分发表投稿成功后状态一周后拒稿理由是回顾性研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ea22192665, createdName=小肥皂, createdTime=Wed Jul 18 00:00:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544025, encodeId=f5df544025fc, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538357, encodeId=98ec53835ee5, content=投稿成功后状态with editor，一周后拒稿，理由是：回顾性研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTkmXU3e5UIm0T3bND74pKNJ481WHRDc02oib8mVWhEyibkuorcDfhiaMwS2OXib3cuiaF1FZQxv0qung/132, createdBy=3e231985516, createdName=先发个20分, createdTime=Fri Jun 23 00:00:00 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518152, encodeId=aa695181521c, content=审稿速度:1.0 经验分享：初始状态accept with revision，修回后3小时接受。神奇的杂志。今年实验室连中两篇，很好投的样子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15c21626952, createdName=SagoWei, createdTime=Fri Jan 08 16:01:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481389, encodeId=e9bc48138950, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2018-07-18 小肥皂

天呐回顾性研究就死路一条了吗先发个分发表投稿成功后状态一周后拒稿理由是回顾性研究

279 0

[GetPortalCommentsPageByObjectIdResponse(id=588116, encodeId=58ae588116dd, content=要不要审稿费和版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e7d5210714, createdName=1475c685m18暂无昵称, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573505, encodeId=7b7f5e350546, content=肿瘤的基础研究可以投该期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572307, encodeId=f0c95e2307af, content=@krygios 这个杂志还是偏临床和外科的。干细胞类，找别的期刊更合适一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Jun 16 08:53:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572297, encodeId=efaa5e22975e, content=看到12年发表过一篇和我类似的干细胞修复的基础文章，虽然和杂志现在发表的文章格格不入，前几天还是投了一篇，两天秒拒，拒稿模板说只有10%的命中率，看来这个杂志不喜欢我这种题材的，记录一下，以后不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Jun 15 00:00:00 CST 2019, time=2019-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559326, encodeId=44fb559326d1, content=天呐回顾性研究就死路一条了吗先发个分发表投稿成功后状态一周后拒稿理由是回顾性研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ea22192665, createdName=小肥皂, createdTime=Wed Jul 18 00:00:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544025, encodeId=f5df544025fc, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538357, encodeId=98ec53835ee5, content=投稿成功后状态with editor，一周后拒稿，理由是：回顾性研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTkmXU3e5UIm0T3bND74pKNJ481WHRDc02oib8mVWhEyibkuorcDfhiaMwS2OXib3cuiaF1FZQxv0qung/132, createdBy=3e231985516, createdName=先发个20分, createdTime=Fri Jun 23 00:00:00 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518152, encodeId=aa695181521c, content=审稿速度:1.0 经验分享：初始状态accept with revision，修回后3小时接受。神奇的杂志。今年实验室连中两篇，很好投的样子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15c21626952, createdName=SagoWei, createdTime=Fri Jan 08 16:01:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481389, encodeId=e9bc48138950, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2017-07-16 wang_di98

徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了

345 0

[GetPortalCommentsPageByObjectIdResponse(id=588116, encodeId=58ae588116dd, content=要不要审稿费和版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e7d5210714, createdName=1475c685m18暂无昵称, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573505, encodeId=7b7f5e350546, content=肿瘤的基础研究可以投该期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572307, encodeId=f0c95e2307af, content=@krygios 这个杂志还是偏临床和外科的。干细胞类，找别的期刊更合适一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Jun 16 08:53:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572297, encodeId=efaa5e22975e, content=看到12年发表过一篇和我类似的干细胞修复的基础文章，虽然和杂志现在发表的文章格格不入，前几天还是投了一篇，两天秒拒，拒稿模板说只有10%的命中率，看来这个杂志不喜欢我这种题材的，记录一下，以后不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Jun 15 00:00:00 CST 2019, time=2019-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559326, encodeId=44fb559326d1, content=天呐回顾性研究就死路一条了吗先发个分发表投稿成功后状态一周后拒稿理由是回顾性研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ea22192665, createdName=小肥皂, createdTime=Wed Jul 18 00:00:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544025, encodeId=f5df544025fc, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538357, encodeId=98ec53835ee5, content=投稿成功后状态with editor，一周后拒稿，理由是：回顾性研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTkmXU3e5UIm0T3bND74pKNJ481WHRDc02oib8mVWhEyibkuorcDfhiaMwS2OXib3cuiaF1FZQxv0qung/132, createdBy=3e231985516, createdName=先发个20分, createdTime=Fri Jun 23 00:00:00 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518152, encodeId=aa695181521c, content=审稿速度:1.0 经验分享：初始状态accept with revision，修回后3小时接受。神奇的杂志。今年实验室连中两篇，很好投的样子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15c21626952, createdName=SagoWei, createdTime=Fri Jan 08 16:01:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481389, encodeId=e9bc48138950, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2017-06-23 先发个20分

投稿成功后状态with editor，一周后拒稿，理由是：回顾性研究。

365 0

[GetPortalCommentsPageByObjectIdResponse(id=588116, encodeId=58ae588116dd, content=要不要审稿费和版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e7d5210714, createdName=1475c685m18暂无昵称, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573505, encodeId=7b7f5e350546, content=肿瘤的基础研究可以投该期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572307, encodeId=f0c95e2307af, content=@krygios 这个杂志还是偏临床和外科的。干细胞类，找别的期刊更合适一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Jun 16 08:53:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572297, encodeId=efaa5e22975e, content=看到12年发表过一篇和我类似的干细胞修复的基础文章，虽然和杂志现在发表的文章格格不入，前几天还是投了一篇，两天秒拒，拒稿模板说只有10%的命中率，看来这个杂志不喜欢我这种题材的，记录一下，以后不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Jun 15 00:00:00 CST 2019, time=2019-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559326, encodeId=44fb559326d1, content=天呐回顾性研究就死路一条了吗先发个分发表投稿成功后状态一周后拒稿理由是回顾性研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ea22192665, createdName=小肥皂, createdTime=Wed Jul 18 00:00:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544025, encodeId=f5df544025fc, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538357, encodeId=98ec53835ee5, content=投稿成功后状态with editor，一周后拒稿，理由是：回顾性研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTkmXU3e5UIm0T3bND74pKNJ481WHRDc02oib8mVWhEyibkuorcDfhiaMwS2OXib3cuiaF1FZQxv0qung/132, createdBy=3e231985516, createdName=先发个20分, createdTime=Fri Jun 23 00:00:00 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518152, encodeId=aa695181521c, content=审稿速度:1.0 经验分享：初始状态accept with revision，修回后3小时接受。神奇的杂志。今年实验室连中两篇，很好投的样子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15c21626952, createdName=SagoWei, createdTime=Fri Jan 08 16:01:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481389, encodeId=e9bc48138950, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2016-01-08 SagoWei

审稿速度:1.0
经验分享：初始状态accept with revision，修回后3小时接受。神奇的杂志。今年实验室连中两篇，很好投的样子

454 0

[GetPortalCommentsPageByObjectIdResponse(id=588116, encodeId=58ae588116dd, content=要不要审稿费和版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e7d5210714, createdName=1475c685m18暂无昵称, createdTime=Fri Apr 03 00:00:00 CST 2020, time=2020-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573505, encodeId=7b7f5e350546, content=肿瘤的基础研究可以投该期刊吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJeAoV0SuZ2MwBg9Gg3eOOXGr4Lgg55k1FlLicb7HAKVql6d8Deg6LwkKChiblJ7iaU7bADtwgHGScww/132, createdBy=e13c1967409, createdName=千军独木, createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572307, encodeId=f0c95e2307af, content=@krygios 这个杂志还是偏临床和外科的。干细胞类，找别的期刊更合适一些, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=167, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Jun 16 08:53:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572297, encodeId=efaa5e22975e, content=看到12年发表过一篇和我类似的干细胞修复的基础文章，虽然和杂志现在发表的文章格格不入，前几天还是投了一篇，两天秒拒，拒稿模板说只有10%的命中率，看来这个杂志不喜欢我这种题材的，记录一下，以后不会再投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0gbVISGnicok3a1pkk9eJjGUG8JvN5oCPbpgzZ0gK3jcOMeNDmiajAUNfvf1vrSzgFDoKdibR60zVzdpBxBOs9cw/0, createdBy=83c82193682, createdName=krygios, createdTime=Sat Jun 15 00:00:00 CST 2019, time=2019-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559326, encodeId=44fb559326d1, content=天呐回顾性研究就死路一条了吗先发个分发表投稿成功后状态一周后拒稿理由是回顾性研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=279, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ea22192665, createdName=小肥皂, createdTime=Wed Jul 18 00:00:00 CST 2018, time=2018-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544025, encodeId=f5df544025fc, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538357, encodeId=98ec53835ee5, content=投稿成功后状态with editor，一周后拒稿，理由是：回顾性研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=365, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKTkmXU3e5UIm0T3bND74pKNJ481WHRDc02oib8mVWhEyibkuorcDfhiaMwS2OXib3cuiaF1FZQxv0qung/132, createdBy=3e231985516, createdName=先发个20分, createdTime=Fri Jun 23 00:00:00 CST 2017, time=2017-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518152, encodeId=aa695181521c, content=审稿速度:1.0 经验分享：初始状态accept with revision，修回后3小时接受。神奇的杂志。今年实验室连中两篇，很好投的样子, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15c21626952, createdName=SagoWei, createdTime=Fri Jan 08 16:01:00 CST 2016, time=2016-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481389, encodeId=e9bc48138950, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=559, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2011-06-29 medwu

看涨哦，明年会不会再涨？

559 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务